Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Wells

Showing results (251-260 of 277) with videos related to

Pageof 28
Sort By:
Blood|September 15, 2025
Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myelomaZhibo Yan, Zhannan Han, Yihui Wang, et al.
Nature Communications|June 4, 2020
Quantifying CDK inhibitor selectivity in live cellsCarrow I Wells, James D Vasta, Cesear R Corona, et al.
Biorxiv : the Preprint Server for Biology|January 12, 2022
Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2Xuan Yang, Rebekah J Dickmander, Armin Bayati, et al.
Journal of Virology|May 25, 2012
The fanconi anemia pathway limits human papillomavirus replicationElizabeth E Hoskins, Richard J Morreale, Stephen P Werner, et al.
ACS Chemical Biology|June 20, 2022
Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-CoronavirusesXuan Yang, Rebekah J Dickmander, Armin Bayati, et al.
Leukemia|June 30, 2023
RUNX1 mutations mitigate quiescence to promote transformation of hematopoietic progenitors in Fanconi anemiaWilliam Marion, Tiago Koppe, Chun-Chin Chen, et al.
Science Advances|June 22, 2022
Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug-resistant gliomasDeanna M Tiek, Beril Erdogdu, Roham Razaghi, et al.
The Journal of Biological Chemistry|March 3, 2005
A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase: molecular mechanisms and anti-inflammatory activity in vivoLawrence de Garavilla, Michael N Greco, Narayanasami Sukumar, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 10, 2018
Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell GrowthLinas J Krulikas, Ian M McDonald, Benjamin Lee, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiologyAnna Castano, Margaux Silvestre, Carrow I Wells, et al.
Pageof 28

Showing results (251-260 of 277) with videos related to

Sort By:
Pageof 28
Blood|September 15, 2025
Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myelomaZhibo Yan, Zhannan Han, Yihui Wang, et al.
Nature Communications|June 4, 2020
Quantifying CDK inhibitor selectivity in live cellsCarrow I Wells, James D Vasta, Cesear R Corona, et al.
Biorxiv : the Preprint Server for Biology|January 12, 2022
Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2Xuan Yang, Rebekah J Dickmander, Armin Bayati, et al.
Journal of Virology|May 25, 2012
The fanconi anemia pathway limits human papillomavirus replicationElizabeth E Hoskins, Richard J Morreale, Stephen P Werner, et al.
ACS Chemical Biology|June 20, 2022
Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-CoronavirusesXuan Yang, Rebekah J Dickmander, Armin Bayati, et al.
Leukemia|June 30, 2023
RUNX1 mutations mitigate quiescence to promote transformation of hematopoietic progenitors in Fanconi anemiaWilliam Marion, Tiago Koppe, Chun-Chin Chen, et al.
Science Advances|June 22, 2022
Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug-resistant gliomasDeanna M Tiek, Beril Erdogdu, Roham Razaghi, et al.
The Journal of Biological Chemistry|March 3, 2005
A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase: molecular mechanisms and anti-inflammatory activity in vivoLawrence de Garavilla, Michael N Greco, Narayanasami Sukumar, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 10, 2018
Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell GrowthLinas J Krulikas, Ian M McDonald, Benjamin Lee, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiologyAnna Castano, Margaux Silvestre, Carrow I Wells, et al.
Pageof 28